Protagenic Therapeutic -CW25PTIXWPreferred / convertible
13F holders, Q1 2024 (March 31)2holders
$0.03avg. 13F price*
At the end of Q1 2024, 2 institutions reported holding Protagenic Therapeutic -CW25 (PTIXW) in their 13F filings. The largest holders were Warberg Asset Management LLC ($6K) and GTS Securities LLC ($1K).
- Company
- Protagenic Therapeutic -CW25
- CUSIP
- 74365N111
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $1 |
Ownership 2 holders
| Warberg Asset Management LLC | — | No change | 177,196 | $6K |
| GTS Securities LLC | — | Add +0.8% | 25,400 | $1K |
"% of holder's portfolio" is PTIXW's weight in each manager's 13F, not the share of Protagenic Therapeutic -CW25 the manager owns.